Pablo Cires Rodríguez

Pablo cires rodríguez

bookmark on deepenrich
location of Pablo Cires RodríguezMadrid, Community of Madrid, Spain
Phone number of Pablo Cires Rodríguez+91 xxxx xxxxx
Followers of Pablo Cires Rodríguez803 followers
  • Timeline

    Jun 2005 - Nov 2023

    Business Unit Head Immunology

    The Janssen Pharmaceutical Companies of Johnson & Johnson
    Madrid, Comunidad de Madrid, España
    Current Company
    Mar 2024 - now

    National Business Director Oncology

    Daiichi Sankyo España
  • About me

    National Business Director/ Business Unit Head /Immunology /Oncology/Infectious Disease /Commercial & Launch Excellence/

  • Education

    • I.g.e. rotary international

      2004 - 2004
      I.g.e. rotary international

      Cultural and professional exchange program

    • Ie business school executive education

      2020 - 2021
      Advanced management program
    • Thames valley university

      2003 - 2004
      Postgraduate law
    • Universidad de oviedo

      1997 - 2003
      Licenciatura derecho
  • Experience

    • The janssen pharmaceutical companies of johnson & johnson

      Jun 2005 - Nov 2023

      • Define, lead and execute the long-term vision and product life cycle management, identifying growth opportunities, target markets and strategic partnerships.• Oversee resource allocation managing P&L budget and operational expenses ensuring efficient utilization.• Ensured compliance with all relevant regulations and company standards.• Led 2 Biologic (Stelara® and Tremfya®) and many different indications market launch, coordinating cross-functional teams, overseeing pricing process and ensuring execution excellence through sales & marketing teams.• Maintained strong relationships with external stakeholders, medical societies and KOLs.• Attracted, developed, and retained key talent within the organization.• Key contributor as G5 country to build EMEA strategic plan in immunology.• 2016-2017 – Business Unit Manager Dermatology & Rheumatologyo Stelara® PSO Management. Leader biologic brand in psoriasiso Stelara® PSA launch: creating new rheumatology team and managed 2 sales structures• 2017-2019 – Business Unit Manager Dermatology & Gastroenterologyo Stelara® IBD launch: creating new gastro team and managed 2 sales structures• 2019-2023 – Business Unit Head Immunologyo Tremfya® launch in psoriasis (2019) and psoriatic arthritis (2022) o 2020 Rare diseases: Retina Gene Therapy readiness leadership. Go to market model definition (2021/22) Show less • Led Prezista®, Intelence® and Rezolsta® launches in Spain including the development of marketing campaigns, pricing strategies, and distribution plans.- Conducted market research and competitive analysis to identify trends, opportunities, and potential risks.• Mentored and developed product management teams, fostering a culture of innovation and continuous improvement. 2 FTEs direct reports.• EMEA team-working. Translating Strategic vision into Operating Company tactics• Value Excellence-Janssen EMEA MKT program: Core developer team member and Vallue Excellence trainer for Janssen EMEA (2015)• James E. Burke Global and EMEA award: most prestigious marketing recognition in Johnson&Johnson for creating awareness campaign Show less

      • Business Unit Head Immunology

        Mar 2016 - Nov 2023
      • Group Product Manager

        Mar 2014 - Mar 2016
      • Product Manager

        Nov 2011 - Mar 2014
      • Visitador Médico Hospitales - VIH

        Sept 2008 - Nov 2011
      • Visitador medico Primaria

        Jun 2005 - Sept 2008
    • Daiichi sankyo españa

      Mar 2024 - now
      National business director oncology
  • Licenses & Certifications